Norway Study- nonselective beta-blocker use at the time of radical prostatectomy (RP) may reduce the risk for prostate cancer recurrence
Nonselective beta-blockers (eg, propranolol, nadolol, timolol, and pindolol) act on both β1- and β2-adrenergic receptors, whereas selective beta-blockers target mainly β1-adrenergic receptor.
Reference
Sivanesan S, Austlid Taskén K, Hartvedt Grytli H.
Nonselective beta-blockers (eg, propranolol, nadolol, timolol, and pindolol) act on both β1- and β2-adrenergic receptors, whereas selective beta-blockers target mainly β1-adrenergic receptor.
Reference
Sivanesan S, Austlid Taskén K, Hartvedt Grytli H.